1 |
Angrisani A, Houben R, Marcuse F, Hochstenbag M, Maessen J, De Ruysscher D, Peeters S. “Radiotherapy for Thymic Epithelial Tumors: What Is The Optimal Dose? A Systematic Review.”. Clinical and Translational Radiation Oncology 2022. [DOI: 10.1016/j.ctro.2022.03.005] [Reference Citation Analysis]
|
2 |
Lideståhl A, Johansson G, Siegbahn A, Lind PA. Estimated Risk of Radiation-Induced Cancer after Thymoma Treatments with Proton- or X-ray Beams. Cancers (Basel) 2021;13:5153. [PMID: 34680302 DOI: 10.3390/cancers13205153] [Reference Citation Analysis]
|
3 |
Rico M, Flamarique S, Casares C, García T, López M, Martínez M, Serrano J, Blanco M, Hernanz R, de Ingunza-Barón L, Marcos FJ, Couñago F. GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours. World J Clin Oncol 2021; 12(4): 195-216 [PMID: 33959475 DOI: 10.5306/wjco.v12.i4.195] [Reference Citation Analysis]
|
4 |
Loap P, Vitolo V, Barcellini A, De Marzi L, Mirandola A, Fiore MR, Vischioni B, Jereczek-Fossa BA, Girard N, Kirova Y, Orlandi E. Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice. Front Oncol 2021;11:738320. [PMID: 34707989 DOI: 10.3389/fonc.2021.738320] [Reference Citation Analysis]
|